Global Point of Care

m-PIMA™ HIV-1/2 Viral Load Test

Point-of-Care HIV Viral Load in Less Than 70 Minutes, Not Months

Designed to provide actionable results while the patient is still present.

WHO recommends a viral load test at 6 months and 12 months, and annually thereafter if the patient is stable on ART1, but few patients receive that level of care.

  • UNAIDS 909090 Goal: 90% of patients on ART virally suppressed by 2020, but only 44% actually are.2
  • Approximately 50% of the viral load testing need in low to middle income countries is unmet.2
  • By 2021 low to middle income countries will need an estimated 30 million viral load tests.3

The m-PIMA™ HIV-1/2 VL test is now commercially available in select countries. Data has been submitted for CE-IVD marking and WHO prequalification. This product is not available in the United States.

View References

  1. WHO: What’s new in treatment monitoring: viral load and CD4 testing. July 2017
  2. Ending AIDS: progress towards the 90-90-90 targets 2017
  3. Lauren & Biyi, LMIC Forecast Demand for Diagnostic Tests 2016-2021, Avenir Health

   

False
accessibility

   

YesNo
accessibility

   

YesNo
More Info